Less than a year after Affymetrix bought eBioscience, the array vendor is finding ways to combine its background in microarray and branched-DNA genotyping and expression with eBio's flow cytometry reagents and multiplex immunoassay portfolios.

This article was originally posted on Feb. 1

Affymetrix this week reported a slight uptick in its second-quarter revenues, which increased 3 percent to $66.4 million from $64.7 million in the year-ago period, beating the average analyst estimate of $65.6 million.

This story was originally posted on Nov. 3
By Justin Petrone

NetBio has been awarded US Patent No. 8,018,593, "Integrated nucleic acid analysis."
Eugene Tan, Heung Lam, Valery Bogdanov, Gregory Kellogg, John Wright, Ulrich Thomann, and Richard Selden are named as inventors on the patent.

IP Roundup


Korea Electro Technology Research Institute of Changwon, Korea, has received US Patent No.

Acknowledging the challenges the firm faces and admitting it has been "slow to respond to technology changes" in the market, Frank Witney said the firm still has some opportunities to restore growth — if it positions its products correctly.

Movers & Shakers


Brandon Ruotolo, Frank Witney, Kevin King, Ronald DePinho, John Mendelsohn, Lynda Chin

IP Roundup


Northwestern University, Affymetrix, Centre National de la Recherche Scientifique

INSERM and Affymetrix win US patents.


The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.